Doximity Inc Cl A (DOCS)

$25.55 +0.32 (1.27%)
Market Cap 4.66B
Revenue (ttm) 570.40M
Net Income (ttm) 223.19M
EPS (ttm) N/A
PE Ratio 20.36
Forward PE 22.90
Profit Margin 39.13%
Debt to Equity Ratio 0.00
Volume 2,253,000
Avg Vol 3,710,316
Day's Range N/A - N/A
Shares Out 184.71M
Stochastic %K 29%
Beta 1.39
Analysts Strong Sell
Price Target $40.90

Company Profile

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants...

Industry: Health Information Services
Sector: Healthcare
Phone: 650 549 4330
Address:
500 3rd Street, Suite 510, San Francisco, United States
TatumHughes58
TatumHughes58 Feb. 20 at 8:29 PM
$DOCS software name basing with tight action watching for confirmation breakout
0 · Reply
erevnon
erevnon Feb. 20 at 12:19 PM
Piper Sandler maintains Doximity $DOCS at Overweight and raises the price target from $40 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
TipRanks
TipRanks Feb. 19 at 11:16 AM
Down Over 30% This Year: Analysts Double Down on These 3 Beaten-Down Stocks https://www.tipranks.com/news/article/down-over-30-this-year-analysts-double-down-on-these-3-beaten-down-stocks $U $TRI $DOCS
0 · Reply
RunnerSignals
RunnerSignals Feb. 18 at 9:50 PM
Upgrades With Momentum $DOCS $PLTR $PANW $ROKU $Z post-upgrade action shows strong volume and sharp rebounds; watch tech and healthcare for short-term follow-through https://stocksrunner.com/news/2026-02-18-top-stock-upgrades-today-in-the-buzz
0 · Reply
11thestate
11thestate Feb. 18 at 3:47 PM
Imagine buying $DOCS at its peak, only to watch it slide hard — and then finding out there may be a way to recover some of your losses. To all $DOCS investors out there, we’ve got some important news for you: https://11th.com/cases/doximity-investor-suit
0 · Reply
Washingtonstate
Washingtonstate Feb. 17 at 10:53 PM
$DOCS
0 · Reply
RunnerSignals
RunnerSignals Feb. 17 at 8:25 PM
Upside Leaders Reset $DOCS $NOW $PGY $ASAN $ITRG 70–150% implied upside. Price still compressed vs targets https://stocksrunner.com/news/2026-02-17-top-stock-upgrades-today-in-the-buzz-spotlight
0 · Reply
Clearly1234
Clearly1234 Feb. 17 at 3:59 AM
$DOCS *not financial advice*
0 · Reply
freddycan
freddycan Feb. 16 at 10:21 PM
$DOCS no longer a need for this company in the industry AI will take their place. It’s basically a software company.
0 · Reply
GrowthWatcher
GrowthWatcher Feb. 13 at 4:21 PM
$DOCS do not underestimate this company
0 · Reply
Latest News on DOCS
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights

Feb 12, 2026, 1:00 PM EST - 8 days ago

Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights

Doximity: Growth Outlook Is Murky

Feb 11, 2026, 9:13 PM EST - 9 days ago

Doximity: Growth Outlook Is Murky

Doximity, Inc. (DOCS) Q3 2026 Earnings Call Transcript

Feb 5, 2026, 10:44 PM EST - 15 days ago

Doximity, Inc. (DOCS) Q3 2026 Earnings Call Transcript

Doximity Stock Is Collapsing After Hours: Here's Why

Feb 5, 2026, 5:04 PM EST - 15 days ago

Doximity Stock Is Collapsing After Hours: Here's Why

Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fifth Consecutive Year

Feb 5, 2026, 4:05 PM EST - 15 days ago

Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fifth Consecutive Year

Doximity Announces Fiscal 2026 Third Quarter Financial Results

Feb 5, 2026, 4:01 PM EST - 15 days ago

Doximity Announces Fiscal 2026 Third Quarter Financial Results

Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026

Jan 15, 2026, 4:01 PM EST - 5 weeks ago

Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026

HALPER SADEH LLC ENCOURAGES DOXIMITY INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 24, 2025, 10:44 AM EST - 2 months ago

HALPER SADEH LLC ENCOURAGES DOXIMITY INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Doximity: Elite Margins, AI Growth, And An Attractive Multiple

Dec 7, 2025, 6:25 AM EST - 2 months ago

Doximity: Elite Margins, AI Growth, And An Attractive Multiple

Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript

Nov 6, 2025, 8:56 PM EST - 3 months ago

Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript

Doximity Announces Fiscal 2026 Second Quarter Financial Results

Nov 6, 2025, 4:01 PM EST - 3 months ago

Doximity Announces Fiscal 2026 Second Quarter Financial Results

Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025

Oct 16, 2025, 4:01 PM EDT - 4 months ago

Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025

Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Oct 1, 2025, 5:30 PM EDT - 5 months ago

Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings

Aug 8, 2025, 11:21 AM EDT - 7 months ago

Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings

Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript

Aug 7, 2025, 9:50 PM EDT - 7 months ago

Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript

Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers

Aug 7, 2025, 4:05 PM EDT - 7 months ago

Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers

Doximity Acquires Pathway, a Leader in AI Clinical Reference

Aug 7, 2025, 4:02 PM EDT - 7 months ago

Doximity Acquires Pathway, a Leader in AI Clinical Reference

Doximity Announces Fiscal 2026 First Quarter Financial Results

Aug 7, 2025, 4:01 PM EDT - 7 months ago

Doximity Announces Fiscal 2026 First Quarter Financial Results

New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures

Jul 31, 2025, 5:00 AM EDT - 7 months ago

New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures

Doximity: Slowing Sales And EBITDA Growth

Jul 23, 2025, 3:35 PM EDT - 7 months ago

Doximity: Slowing Sales And EBITDA Growth

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

Jul 17, 2025, 4:01 PM EDT - 7 months ago

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

Doximity Crushes The Rule Of 40 - Try Rule Of 58

Jul 2, 2025, 10:36 AM EDT - 8 months ago

Doximity Crushes The Rule Of 40 - Try Rule Of 58

Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'

Jun 18, 2025, 7:18 AM EDT - 8 months ago

Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'

Doximity to Present at the William Blair 45th Annual Growth Stock Conference

May 21, 2025, 4:01 PM EDT - 9 months ago

Doximity to Present at the William Blair 45th Annual Growth Stock Conference

Doximity Stock 7.8% Higher After Key Trading Signal

May 19, 2025, 7:47 AM EDT - 9 months ago

Doximity Stock 7.8% Higher After Key Trading Signal

These Analysts Cut Their Forecasts On Doximity After Q4 Results

May 16, 2025, 1:51 PM EDT - 10 months ago

These Analysts Cut Their Forecasts On Doximity After Q4 Results

Globant, Doximity, Applied Materials And Other Big Stocks Moving Lower In Friday's Pre-Market Session

May 16, 2025, 9:09 AM EDT - 10 months ago

Globant, Doximity, Applied Materials And Other Big Stocks Moving Lower In Friday's Pre-Market Session

AMAT GLOB

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript

May 15, 2025, 8:35 PM EDT - 10 months ago

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript

Doximity Stock Drops 20% After Outlook Disappoints

May 15, 2025, 5:55 PM EDT - 10 months ago

Doximity Stock Drops 20% After Outlook Disappoints

Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results

May 15, 2025, 4:01 PM EDT - 10 months ago

Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Doximity: Strong Fundamentals And Pharma Tailwinds Meet An Overpriced Valuation

May 1, 2025, 9:23 AM EDT - 10 months ago

Doximity: Strong Fundamentals And Pharma Tailwinds Meet An Overpriced Valuation

Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

Apr 24, 2025, 4:01 PM EDT - 10 months ago

Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS

Feb 21, 2025, 9:00 AM EST - 1 year ago

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS

Doximity: Rating Downgrade As Near-Term Upside Is Priced In

Feb 14, 2025, 5:53 PM EST - 1 year ago

Doximity: Rating Downgrade As Near-Term Upside Is Priced In

Doximity Momentum, Big Money Support Stays Strong

Feb 14, 2025, 7:49 AM EST - 1 year ago

Doximity Momentum, Big Money Support Stays Strong

Doximity to Participate in the Raymond James 46th Annual Institutional Investors Conference

Feb 13, 2025, 4:29 PM EST - 1 year ago

Doximity to Participate in the Raymond James 46th Annual Institutional Investors Conference

Doximity Q3 Earnings: Outpacing Even Management's Expectations

Feb 10, 2025, 12:04 PM EST - 1 year ago

Doximity Q3 Earnings: Outpacing Even Management's Expectations

Digital Health Platform Doximity Stock Jumps On Upbeat Annual Outlook, Analysts Raise Forecast

Feb 7, 2025, 1:24 PM EST - 1 year ago

Digital Health Platform Doximity Stock Jumps On Upbeat Annual Outlook, Analysts Raise Forecast

Doximity shares pop 30% on revenue beat, rosy guidance

Feb 7, 2025, 10:38 AM EST - 1 year ago

Doximity shares pop 30% on revenue beat, rosy guidance

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 8:01 PM EST - 1 year ago

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

Doximity shares soar 21% after company beats on revenue, raises fiscal year guidance

Feb 6, 2025, 5:14 PM EST - 1 year ago

Doximity shares soar 21% after company beats on revenue, raises fiscal year guidance

Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fourth Consecutive Year

Feb 6, 2025, 4:02 PM EST - 1 year ago

Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fourth Consecutive Year

Doximity Announces Fiscal 2025 Third Quarter Financial Results

Feb 6, 2025, 4:01 PM EST - 1 year ago

Doximity Announces Fiscal 2025 Third Quarter Financial Results

Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025

Jan 16, 2025, 4:01 PM EST - 1 year ago

Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025

Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution

Jan 13, 2025, 6:51 AM EST - 1 year ago

Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution

Stock Picks From Seeking Alpha's December 2024 New Analysts

Jan 7, 2025, 8:00 AM EST - 1 year ago

Stock Picks From Seeking Alpha's December 2024 New Analysts

ALGM CE CEG ETD FDVV FSS HOG

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

Dec 24, 2024, 8:00 AM EST - 1 year ago

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

DXCM GDRX HIMS OSCR PGNY TDOC TEM

Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care

Dec 17, 2024, 8:00 AM EST - 1 year ago

Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care

Doximity: Strong Fundamentals And Growth Potential Makes It Attractive

Dec 6, 2024, 7:52 AM EST - 1 year ago

Doximity: Strong Fundamentals And Growth Potential Makes It Attractive

TatumHughes58
TatumHughes58 Feb. 20 at 8:29 PM
$DOCS software name basing with tight action watching for confirmation breakout
0 · Reply
erevnon
erevnon Feb. 20 at 12:19 PM
Piper Sandler maintains Doximity $DOCS at Overweight and raises the price target from $40 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
TipRanks
TipRanks Feb. 19 at 11:16 AM
Down Over 30% This Year: Analysts Double Down on These 3 Beaten-Down Stocks https://www.tipranks.com/news/article/down-over-30-this-year-analysts-double-down-on-these-3-beaten-down-stocks $U $TRI $DOCS
0 · Reply
RunnerSignals
RunnerSignals Feb. 18 at 9:50 PM
Upgrades With Momentum $DOCS $PLTR $PANW $ROKU $Z post-upgrade action shows strong volume and sharp rebounds; watch tech and healthcare for short-term follow-through https://stocksrunner.com/news/2026-02-18-top-stock-upgrades-today-in-the-buzz
0 · Reply
11thestate
11thestate Feb. 18 at 3:47 PM
Imagine buying $DOCS at its peak, only to watch it slide hard — and then finding out there may be a way to recover some of your losses. To all $DOCS investors out there, we’ve got some important news for you: https://11th.com/cases/doximity-investor-suit
0 · Reply
Washingtonstate
Washingtonstate Feb. 17 at 10:53 PM
$DOCS
0 · Reply
RunnerSignals
RunnerSignals Feb. 17 at 8:25 PM
Upside Leaders Reset $DOCS $NOW $PGY $ASAN $ITRG 70–150% implied upside. Price still compressed vs targets https://stocksrunner.com/news/2026-02-17-top-stock-upgrades-today-in-the-buzz-spotlight
0 · Reply
Clearly1234
Clearly1234 Feb. 17 at 3:59 AM
$DOCS *not financial advice*
0 · Reply
freddycan
freddycan Feb. 16 at 10:21 PM
$DOCS no longer a need for this company in the industry AI will take their place. It’s basically a software company.
0 · Reply
GrowthWatcher
GrowthWatcher Feb. 13 at 4:21 PM
$DOCS do not underestimate this company
0 · Reply
ConsistentSpike
ConsistentSpike Feb. 13 at 2:58 PM
$DOCS $TTD $BTC.X $YELP
0 · Reply
ConsistentSpike
ConsistentSpike Feb. 12 at 6:35 PM
$CART $DOCS $TTD
0 · Reply
Washingtonstate
Washingtonstate Feb. 12 at 5:36 PM
$DOCS
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 11 at 9:08 PM
$DOCS Share Price: $25.95 Contract Selected: Aug 21, 2026 $25 Calls Buy Zone: $4.59 – $5.67 Target Zone: $8.50 – $10.38 Potential Upside: 75% ROI Time to Expiration: 190 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
anachartanalyst
anachartanalyst Feb. 11 at 3:02 PM
$DOCS https://anachart.com/wp-content/uploads/ana_temp/1770822108_soc-img.jpg
0 · Reply
NasdaqKnight
NasdaqKnight Feb. 11 at 8:20 AM
UK AI Smart Portfolio – Feb 2026 Update 🇬🇧 AI-driven picks are live and ready to track: If this is helpful to you, tap @NasdaqKnight Healthcare: $GSK, $AZN — global pharma leaders innovating at scale. Tech/Digital: $KNOS , — riding the software & digital transformation wave. Industrials: $AHT, — boosting infrastructure & industrial exposure. Consumer/Brands: $GAW, $DOCS, — premium retail & lifestyle growth. 📊 Why it matters: Built on AI analytics, designed for long-term alpha, beating traditional benchmarks month after month. 💡 Hot take: This mix balances defensive healthcare with high-growth tech & consumer plays — perfect for UK-focused investors seeking diversification with an AI edge. Trending, data-backed, and ready to move — follow momentum and monitor updates.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 11 at 12:29 AM
$DOCS Current Stock Price: $27.25 Contracts to trade: $27.5 DOCS Feb 20 2026 Call Entry: $0.80 Exit: $1.04 ROI: 30% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
RunnerSignals
RunnerSignals Feb. 10 at 8:51 PM
Stock Upgrades Today $ARES $APP $AVGO $DOCS $MBOT Strong Buy vibes and bold upside forecasts. Analysts leaning bullish https://stocksrunner.com/news/2026-02-10-stock-upgrades-today
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 9 at 10:33 PM
$DOCS RSI: 8.28, MACD: -3.6597 Vol: 4.36, MA20: 38.02, MA50: 42.68 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
erevnon
erevnon Feb. 9 at 6:11 PM
Goldman Sachs maintains Doximity $DOCS at Neutral and lowers the price target from $46 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Washingtonstate
Washingtonstate Feb. 9 at 3:39 PM
$DOCS
0 · Reply
resistancebreakers
resistancebreakers Feb. 9 at 1:32 PM
$DOCS
0 · Reply